UnitedHealth Faces Chart Risks Ahead of Earnings

UnitedHealth Group shares reached $434 this year after a series of management changes and a larger-than-expected increase in Medicare Advantage payments. Ahead of its earnings report this week, the stock shows a rising wedge on daily charts and weakening momentum indicators.

The stock has risen alongside peers in the health-insurance sector and is up about 66% from its low this year. Company actions cited by investors include management changes and an independent review of operations. The administration increased Medicare Advantage payments by more than 2%, a change estimated to add over $13 billion to the market pool for insurers with large Medicare Advantage footprints.

On technical charts, recent price action has narrowed into a rising wedge, formed by two converging upward trendlines. Traders monitor such formations because a breakout often occurs as the trendlines meet. Momentum indicators show divergence: the Relative Strength Index has fallen toward the neutral 50 level while the Percentage Price Oscillator is approaching a zero-line crossover. Those readings reflect weakening momentum while the price moved higher.

Consensus estimates ahead of the report point to quarterly revenue near $110 billion, third-quarter guidance around $110.89 billion and full-year revenue expectations of about $444.1 billion. Market participants will assess whether the results and guidance align with recent analyst revisions and the stock’s re-rating.

UnitedHealth’s forward price-to-earnings ratio is about 24.8, roughly in line with its five-year average near 25. Large investors trimmed positions earlier this year; Berkshire Hathaway reduced its stake. Analyst price targets vary: one bank places a $380 target, while other firms have raised targets above $460. The street consensus target sits near $417, below recent trading levels.

Key technical levels cited by market watchers are near $400 on the downside and $450 on the upside. The earnings release and subsequent trading are likely to test those levels.

UnitedHealth has reported stronger recent financial results and raised annual guidance as management implemented strategic changes. The combination of policy changes, corporate adjustments and analyst revisions has contributed to the stock’s gains this year.